Sesamol protects MIN6 pancreatic beta cells against simvastatin-induced toxicity by restoring mitochondrial membrane potentials

[1]  R. Lobo,et al.  Sesamol and Health–A Comprehensive Review , 2019, Indian Journal of Pharmaceutical Education and Research.

[2]  M. Nampoothiri,et al.  Neuroprotective potential of methanolic extract of Saraca asoca bark against doxorubicin-induced neurotoxicity , 2019, Pharmacognosy Magazine.

[3]  R. Roberts,et al.  Simvastatin Inhibits L-Type Ca2+-Channel Activity Through Impairment of Mitochondrial Function. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  M. Topal.  The inhibition profile of sesamol against α-glycosidase and acetylcholinesterase enzymes , 2019, International Journal of Food Properties.

[5]  V. R. Murty,et al.  Amelioration of arsenic-induced oxidative stress in CHO cells by Ixora coccinea flower extract , 2018, 3 Biotech.

[6]  K. Maki,et al.  Statin use and risk for type 2 diabetes: what clinicians should know , 2018, Postgraduate medicine.

[7]  M. Nampoothiri,et al.  Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats , 2018, Cytotechnology.

[8]  M. Bugliani,et al.  Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress , 2017, Scientific Reports.

[9]  Xuebo Liu,et al.  Sesamol ameliorates diet-induced obesity in C57BL/6J mice and suppresses adipogenesis in 3T3-L1 cells via regulating mitochondria-lipid metabolism. , 2017, Molecular nutrition & food research.

[10]  Neetinkumar D. Reddy,et al.  In vitro and in vivo anticancer studies of 2'-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest , 2017, EXCLI journal.

[11]  Agisha Raaje.  Statin Induced Diabetes , 2017 .

[12]  Sridevi Annapurna Singh,et al.  Inhibition of lipoxygenase by sesamol corroborates its potential anti-inflammatory activity. , 2017, International journal of biological macromolecules.

[13]  Grace Juyun Kim,et al.  Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database , 2016, Therapeutics and clinical risk management.

[14]  A. Tiwari,et al.  Synthesis and evaluation of selected 1,3,4-oxadiazole derivatives for in vitro cytotoxicity and in vivo anti-tumor activity , 2016, Cytotechnology.

[15]  Shuiping Zhao,et al.  Different effects of statins on induction of diabetes mellitus: an experimental study , 2015, Drug design, development and therapy.

[16]  Yan Pan,et al.  Curcumin attenuates palmitate-induced apoptosis in MIN6 pancreatic β-cells through PI3K/Akt/FoxO1 and mitochondrial survival pathways , 2015, Apoptosis.

[17]  K. Bairy,et al.  Statin use and risk of diabetes mellitus. , 2015, World journal of diabetes.

[18]  U. Aiman,et al.  Statin induced diabetes and its clinical implications , 2014, Journal of pharmacology & pharmacotherapeutics.

[19]  J. Mudgal,et al.  Sesamol Treatment Reduces Plasma Cholesterol and Triacylglycerol Levels in Mouse Models of Acute and Chronic Hyperlipidemia , 2013, Lipids.

[20]  L. Mascitelli,et al.  Do Statins Cause Diabetes? , 2013, Current Diabetes Reports.

[21]  P. Srinivasan,et al.  Sesamol attenuates oxidative stress–mediated experimental acute pancreatitis in rats , 2012, Human & experimental toxicology.

[22]  G. Watts,et al.  Coenzyme Q10 Improves Endothelial Dysfunction in Statin-Treated Type 2 Diabetic Patients , 2009, Diabetes Care.

[23]  T. C. Smale.  NEW INHIBITORS OF CHOLESTEROGENESIS PRODUCED BY PENICILLIUM CITRINUM , 2006 .

[24]  O. Andersen,et al.  Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics. , 2003, Biochemistry.

[25]  C. Stancu,et al.  Statins: mechanism of action and effects , 2001, Journal of cellular and molecular medicine.

[26]  M. Esposti.  Inhibitors of NADH-ubiquinone reductase: an overview. , 1998 .

[27]  Y. Tsujita,et al.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. , 1976, The Journal of antibiotics.